# Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

> **NCT00665431** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 610 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** PN 400 (VIMOVO)
- **DRUG:** celebrex
- **OTHER:** Placebo
- **DRUG:** Rescue Antacid

## Key facts

- **NCT ID:** NCT00665431
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 610 (ACTUAL)
- **Last updated:** 2011-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665431, "Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00665431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*